Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Celldex Therapeutics buy Morgan Stanley

Celldex Therapeutics
Start price
€18.40
20.03.25 / 50%
Target price
€42.18
20.03.26
Performance (%)
27.17%
Price
€23.40
08.01.26
Summary
This prediction is currently active. The prediction currently has a performance of 27.17%. This prediction currently runs until 20.03.26. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Celldex Therapeutics 0.909% 0.909%
iShares Core DAX® 2.659% 4.844%
iShares Nasdaq 100 0.916% -0.554%
iShares Nikkei 225® 2.426% 1.598%
iShares S&P 500 1.230% 1.039%

Comments by Morgan_Stanley for this prediction

In the thread Celldex Therapeutics diskutieren
Prediction Buy
Perf. (%) 27.17%
Target price 42.182
Change
Ends at 20.03.26

Celldex Therapeutics, Inc. (NASDAQ: CLDX) is now covered by analysts at Morgan Stanley. They set an "overweight" rating and a $46.00 price target on the stock.
Ratings data for CLDX provided by MarketBeat

Morgan Stanley 
0
Report Share
20.03.25

Stopped prediction by Morgan_Stanley for Celldex Therapeutics

buy
Celldex Therapeutics

Start price
Target price
Perf. (%)
€16.30
09.05.25
€38.34
09.05.26
43.56%
08.01.26

Morgan Stanley 
09.05.25 50%